Newsroom

Sorted by: Latest
-

Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, t...
-

ReNew Announces Long-Term Agreement With Google to Enable 150 MW Solar Project in Rajasthan

GURUGRAM, India--(BUSINESS WIRE)--ReNew Energy Global Plc today announced its long-term agreement with Google to enable the development of a new 150 MW solar project in Rajasthan....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - April 15.12.2025 FAPR.LN IE000WX2HZQ7 150,002.00 USD 3,636,991.78 24.246  ...
-

Riassunto: RoslinCT e Ayrmid Ltd. annunciano l'espansione della collaborazione strategica per produrre Omisirge® (omidubicel-onlv) per la seconda indicazione approvata dall'FDA nell'anemia aplastica grave (SAA)

BOSTON--(BUSINESS WIRE)--Ayrmid Ltd., la società madre di Gamida Cell Inc., un pioniere nelle terapie cellulari che lavora per trasformare le cellule in potenti terapie e RoslinCT, un'organizzazione di sviluppo e produzione a contratto di terapie cellulari e geniche, oggi hanno annunciato l'espansione della loro collaborazione strategica per includere l'esecuzione di un accordo di fornitura commerciale a supporto della produzione di Omisirge® (omidubicel-onlv). Il testo originale del presente a...
-

RoslinCT et Ayrmid Ltd. annoncent l’élargissement de leur partenariat stratégique pour la fabrication d’Omisirge® (omidubicel-onlv) pour une deuxième indication approuvée par la FDA dans le traitement de l’anémie aplasique sévère (AAS)

BOSTON--(BUSINESS WIRE)--Ayrmid Ltd., société mère de Gamida Cell Inc., une société pionnière dans le domaine de la thérapie cellulaire qui transforme les cellules en puissants traitements thérapeutiques, et RoslinCT, leader mondial dans le développement et la fabrication sous contrat de thérapies cellulaires et géniques, ont annoncé aujourd’hui l’extension de leur partenariat stratégique afin d’inclure la signature d’un accord d’approvisionnement commercial visant à soutenir la production d’Om...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF- August 15.12.2025 GAUG LN IE000TGSG3Y5  650,002.00 USD  22,788,322.88   35.059  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Scarce Resources UCTS ETF 15.12.2025 SCAR LN IE000BW2B3J3   25,002.00 USD    670,458.60   26.816  ...
-

Vox AI Partners with Adyen to Bring Payments to Drive-Thru Order Terminals

AMSTERDAM--(BUSINESS WIRE)--Vox AI Partners with Adyen to Bring Payments to Drive-Thru Order Terminals...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST INDXX FUTURE ECONOMY METALS UCITS ETF 15.12.2025 METL LN IE000UDFKE13   75,002.00 USD   2,267,444.93   30.232  ...
-

Globalstar and Skydio Complete First Drone Flight on Globalstar Band n53TM and XCOM RAN

COVINGTON, La.--(BUSINESS WIRE)--Globalstar (NASDAQ: GSAT), a next-generation telecommunications infrastructure and technology provider, today announces the successful completion of a joint technology trial with Skydio, the leading U.S. drone manufacturer and world leader in autonomous flight. The companies validated compatibility between the Skydio X10 and Globalstar’s licensed Band n53 spectrum, as well as Globalstar’s XCOM RAN private 5G platform. Skydio and Globalstar’s trial evaluated Band...